Research indicates that GALP modulates gonadotropin secretion via the hypothalamic-pituitary-ovarian (HPO) axis, while the characteristic LH/FSH ratio imbalance and hyperandrogenemia in PCOS patients may further exacerbate IR, a core pathogenic mechanism of GDM (34). The gene discussed is GALP; the disease is polycystic ovary syndrome.